Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026)
Treace Medical Concepts filings provide 4 years of Non Operating Investment Income readings, the most recent being -$11000.0 for Q4 2025.
- On a quarterly basis, Non Operating Investment Income rose 88.3% to -$11000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$25000.0, a 62.12% increase, with the full-year FY2025 number at -$25000.0, up 62.12% from a year prior.
- Non Operating Investment Income hit -$11000.0 in Q4 2025 for Treace Medical Concepts, down from $33000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $311000.0 in Q4 2023 to a low of -$163000.0 in Q2 2023.
- Median Non Operating Investment Income over the past 4 years was -$27000.0 (2022), compared with a mean of $5538.5.
- Biggest five-year swings in Non Operating Investment Income: surged 1251.85% in 2023 and later tumbled 224.14% in 2024.
- Treace Medical Concepts' Non Operating Investment Income stood at -$27000.0 in 2022, then surged by 1251.85% to $311000.0 in 2023, then tumbled by 130.23% to -$94000.0 in 2024, then skyrocketed by 88.3% to -$11000.0 in 2025.
- The last three reported values for Non Operating Investment Income were -$11000.0 (Q4 2025), $33000.0 (Q3 2025), and -$7000.0 (Q2 2025) per Business Quant data.